SAR442501
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAR442501, covering 2024-08-27 to 2026-06-25. Get the full timeline:
Most recent: Clinical Trial Results: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia [Phase 2]